Use of contrast agents for liver MRI

Radiography

Volumn 13, Issue SUPPLL. 1, 2007, Pages

  Ward, Janice ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Contrast agents; Liver; MRI

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM;

ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; EXTRACELLULAR SPACE; LIVER CELL; LIVER CELL CARCINOMA; LIVER DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RETICULOENDOTHELIAL SYSTEM;

EID: 37349014497     PISSN: 10788174     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radi.2006.09.002     Document Type: Article

References (79)

1. In: Wiliam P.L., Warwick R., Dyson M., and Bannister L.H. (Eds). Gray's anatomy. 37th ed. (1989), Churchill Livingstone, London, New York
2. Oi H., Murakami T., Kim T., Matsushita M., Kishimoto H., and Nakamura H. Dynamic MR imaging and early-phase CT for detecting small intrahepatic metastases of hepatocellular carcinoma. AJR 166 (1996) 369-374
3. Peterson M.S., Baron R.L., and Murakami T. Hepatic malignancies: usefulness of acquisition of multiple arterial and portal venous phase images at dynamic gadolinium-enhanced MR imaging. Radiology 201 (1996) 337-345
4. Tang Y., Yamashita Y., Arakawa A., Namimoto T., Mitsuzaki K., Abe Y., et al. Detection of hepatocellular carcinomas arising in cirrhotic livers: comparison of gadolinium-and ferumoxides-enhanced MR imaging. AJR 172 (1999) 1547-1554
5. Yamashita Y., Mitsuzaki K., Yi T., Ogata I., Nishiharu T., Urata J., et al. Small hepatocellular carcinoma in patients with chronic liver damage: prospective comparison of detection with dynamic MR imaging and helical CT of the whole liver. Radiology 200 (1996) 79-84
6. Blakeborough A., Ward J., Wilson D., Griffith M., Kajiya Y., Guthrie J.A., et al. Hepatic lesion detection at MR imaging: a comparative study with four sequences. Radiology 203 (1997) 759-765
7. Hagspiel K.D., Neidl K.F.W., Eichenberger A.C., Weder W., and Marincek B. Detection of liver metastases: comparison of superparamagnetic iron oxide-enhanced MR imaging at 1.5 T with dynamic CT, intraoperative US and percutaneous US. Radiology 196 (1995) 471-478
8. Muller R.D., Vogel K., Neumann K., Hirche H., Barkhausen J., Stoblen F., et al. SPIO-MR imaging versus double-phase spiral CT in detecting malignant lesions of the liver. Acta Radiol 40 (1999) 628-635
9. Reimer P., Jähnke N., Fiebich M., Schima W., Deckers F., Marx C., et al. Hepatic lesion detection and characterization: value of non-enhanced MR imaging, superparamagnetic iron oxide-enhanced MR imaging and spiral CT-ROC analysis. Radiology 217 (2000) 152-158
10. Ward J., Chen F., Guthrie J.A., Wilson D., Lodge J.P., Wyatt J.I., et al. Hepatic lesion detection after superparamagnetic iron oxide enhancement: comparison of five T2-Weighted sequences at 1.0 T by using alternative-free response receiver operating characteristic analysis. Radiology 214 (2000) 159-166
11. Ward J., Naik K.S., Guthrie J.A., Wilson D., and Robinson P.J. Hepatic lesion detection: comparison of MR imaging after the administration of superparamagnetic iron oxide with dual-phase CT by using alternative-free response receiver operating characteristic analysis. Radiology 210 (1999) 459-566
12. Ward J., Guthrie J.A., Wilson D., Arnold P., Lodge J.P., Toogood G.J., et al. Colorectal hepatic metastases, detection with SPIO-enhanced breathhold imaging: comparison of optimised sequences at 1.5 T. Radiology 228 3 (2003) 709-718
13. Ward J., Robinson P.J., Guthrie J.A., Downing S., Wilson D., Lodge J.P., et al. Liver metastases in candidates for hepatic resection: comparison of thin-slice helical CT, high-resolution 3D dynamic gadolinium-enhanced MR and SPIO-enhanced T2W gradient echo imaging. Radiology 237 (2005) 170-180
14. Reimer P., Schneider G., and Schima W. Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications. Eur Radiol 14 (2004) 559-578
15. King L.J., Burkill G.J., Scurr E.D., Vlavianos P., Murrary-Lyons I., and Healy J.C. MnDPDP enhanced magnetic resonance imaging of focal liver lesions. Clin Radiol 57 (2002) 1047-1057
16. Padovani B., Lecesne R., Raffaelli C., Chevallier P., Drouillard J., Bruneton J.N., et al. Tolerability and utility of mangafodipir trisodium injection (MnDPDP) at the dose of 5 mμmol/kg body weight in detecting focal liver tumors: results of phase III trial using an infusion technique. Eur J Radiol 23 (1996) 205-211
17. Federle M.P., Chezmar J.L., Rubin D.L., Weinreb J.C., Freeny P.C., Semelka R.C., et al. Efficacy and safety of mangafodipir trisodium (MnDPDP) injection for hepatic MRI in adults: results of the U.S. multicenter phase III clinical trials. J Magn Reson Imaging 12 (2000) 186-197
18. Braga H.J., Choti M.A., Lee V.S., Paulson E.K., Siegelman E.S., and Bluemke D.A. Liver lesions: manganese-enhanced MR and dual-phase helical CT for preoperative detection and characterization comparison with receiver operator characteristic analysis. Radiology 223 (2002) 525-531
19. Mann G.N., Marx H.F., Lai L.L., and Wagman L.D. Clinical and cost effectiveness of a new hepatocellular MRI contrast Agent, mangafodipir trisodium, in the preoperative assessment of liver resectability. Ann Surg Oncol 8 (2001) 573-579
20. Bartolozzi C., Donati F., Cioni D., Crocetti L., and Lencioni R. MnDPDP-enhanced MRI vs dual-phase spiral CT in the detection of hepatocellular carcinoma in cirrhosis. Eur Radiol 120 (2000) 1697-1702
21. Kim S.K., Kim S.H., Lee W.J., Kim H., Seo J.W., Choi D., et al. Preoperative detection of hepatocellular carcinoma: ferumoxides-enhanced versus mangafodipir trisodium-enhanced MR imaging. AJR 179 (2002) 741-750
22. Kuwatsuru R., Kadoya M., Ohtomo K., Tanimoto A., Hirohashi S., Murakami T., et al. Comparison of gadobenate dimeglumine with gadopentetate dimeglumine for magnetic resonance imaging of liver tumors. Invest Radiol 36 (2001) 632-641
23. Petersein J., Spinazzi A., Giovagnoni A., Soyer P., Terrier F., Lencioni R., et al. Focal liver lesions: evaluation of the efficacy of gadobenate dimeglumine in MR imaging - a multicenter phase III clinical study. Radiology 215 (2000) 727-736
24. Schneider G., Maas R., Schultze Kool L., Rummeny E., Gehl H.B., Lodemann K.P., et al. Low-dose gadobenate dimeglumine versus standard dose gadopentetate dimeglumine for contrast-enhanced magnetic resonance imaging of the liver: an intra-individual crossover comparison. Invest Radiol 38 (2003) 85-94
25. Stern W., Schick F., Kopp A.F., Reimer P., Shamsi K., Claussen C.D., et al. Dynamic MR imaging of liver metastases with Gd-EOB-DTPA. Acta Radiologica 41 (2000) 255-262
26. Huppertz A., Balzer T., Blakeborough A., Breuer J., Giovagnoni A., Heinz-Peer G., et al. Improved detection of focal liver lesions in MRI: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings. Radiology 230 (2004) 266-275
27. Reimer P., Rummeny E.J., Daldrup H.E., Hesse T., Balzer T., Tombach B., et al. Enhancement characteristics of liver metastases, hepatocellular carcinomas and haemangiomas with Gd-EOB-DTPA: preliminary results with dynamic MR imaging. Euro Radiol 7 2 (1997) 275-280
28. Hamm B., Thoeni R.F., Gould R.G., Bernardino M.E., Luning M., Saini S., et al. Focal liver lesions: characterisation with non-enhanced and dynamic contrast material-enhanced MR imaging. Radiology 190 (1994) 417-423
29. Hawighorst H., Schoenberg S.O., Knopp M.V., Essig M., Miltner P., van Kaick G., et al. Hepatic lesions: morphologic and functional characterisation with multiphase breath-hold 3D gadolinium-enhanced MR angiography-initial results. Radiology 210 (1999) 89-96
30. Larson R.E., Semelka R.C., Bagley A.S., Molina P.L., Brown E.D., Lee J.K., et al. Hypervascular malignant liver lesions: comparison of various MR imaging pulse sequences and dynamic CT. Radiology 192 (1994) 393-399
31. Mahfouz A.-E., Hamm B., Taupitz M., and Wolf K.J. Hypervascular liver lesions differentiation of focal nodular hyperplasia from malignant tumours with dynamic gadolinium-enhanced MR imaging. Radiology 186 (1993) 133-138
32. Mahfouz A.E., Hamm B., and Wolf K.J. Peripheral washout: a sign of malignancy on dynamic gadolinium-enhanced MR images of focal liver lesions. Radiology 190 (1994) 49-52
33. Mitchell D.G., Saini S., Weinreb J., De Lange E.E., Runge V.M., Kuhlman J.E., et al. Hepatic metastases and cavernous hemangiomas: distinction with standard- and triple-dose gadoteridol-enhanced MR imaging. Radiology 193 (1994) 49-57
34. Grandin C., Van Beers B.E., Robert A., Gigot J.F., Geubel A., Pringot J., et al. Benign hepatocellular tumors: MRI after superparamagnetic iron oxide administration. J Comput Assist Tomogr 19 3 (1995) 412-418
35. Poeckler-Schoeniger C., Koepke J., Gueckel F., Sturm J., and Georgi M. MRI with superparamagnetic iron oxide: efficacy in the detection and characterisation of focal hepatic lesions. Magn Reson Imaging 17 (1999) 383-392
36. Precetti-Morel S., Bellin M.F., Ghebontni L., Zaim S., Opolon P., Poynard T., et al. Focal nodular hyperplasia of the liver on ferumoxides-enhanced MR imaging: features on conventional spin-echo, fast spin-echo and gradient-echo pulse sequences. Eur Radiol 9 (1999) 1535-1542
37. Ba-Ssalamah A., Schima W., Schmook M.T., Linnau K.F., Schibany N., Helbich T., et al. Atypical focal nodular hyperplasia of the liver: imaging features of non-specific and liver-specific MR contrast agents. AJR 179 (2002) 1447-1456
38. Oudkerk M., Torres C.G., Song B., Konig M., Grimm J., Fernandez-Cuadrado J., et al. Characterization of liver lesions with mangafodipir trisodium-enhanced MR imaging: multicenter study comparing MR and dual-phase spiral CT. Radiology 223 (2002) 517-524
39. Helmberger T.K., Laubenberger J., Rummeny E., Jung G., Sievers K., Dohring W., et al. MRI characteristics in focal hepatic disease before and after administration of MnDPDP: discriminant analysis as a diagnostic tool. Eur Radiol 12 (2002) 62-70
40. Morana G., Grazioli L., Schneider G., Testoni M., Menni K., Chiesa A., et al. Hypervascular hepatic lesions: dynamic and late enhancement pattern with Gd-BOPTA. Acta Radiol 9 Suppl. 2 (2002) 476-479
41. Grazioli L., Morana G., Kirchin M.A., Caccia P., Romanini L., Bondioni M.P., et al. MRI of focal nodular hyperplasia (FNH) with gadobenate dimeglumine (Gd-BOPTA) and SPIO (ferumoxides): an intra-individual comparison. J Magn Reson Imaging 17 (2003) 593-602
42. Grazioli L., Morana G., Kirchin M.A., and Schneider G. Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study. Radiology 236 (2005) 166-177
43. Vogl T. Enhancement of malignant and benign focal liver lesions using Gd-EOB-DTPA and Gd-DTPA enhanced MRI in the same patient. International conference of MRI of the abdomen and pelvis (1995), H.M. Hauschild Ltd, Bremen, Munich, Germany
44. Huppertz A., Haraida S., Kraus A., Zech C.J., Scheidler J., Breuer J., et al. Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: correlation with histopathologic findings and spiral CT - initial observations. Radiology 234 (2005) 468-478
45. Vogl T.J., Kummel S., Hammerstingl R., Schellenbeck M., Schumacher G., Balzer T., et al. Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA. Radiology 200 (1996) 59-67
46. Runge V.M. A comparison of two MR hepatobiliary gadolinium chelates: Gd-BOPTA and Gd-EOB-DTPA. J Comp Assist Tomogr 22 (1998) 643-650
47. Tanimoto A., Satoh Y., Yuasa Y., Jinzaki M., and Hiramatsu K. Performance of Gd-EOB-DTPA and superparamagnetic iron oxide particles in the detection of primary liver cancer: a comparative study by alternative free-response receiver operating characteristic analysis. J Magn Reson Imaging 7 (1997) 120-124
48. Gaa J., Hatabu H., Jenkins R.L., Finn J.P., and Edelman R.R. Liver masses: replacement of conventional T2-weighted spin-echo MR imaging with breath-hold MR imaging. Radiology 200 (1996) 459-464
49. Hittmair K., Trattnig S., Herold C.J., Breitenseher M., and Kramer J. Comparison between conventional and fast spin-echo STIR sequences. Acta Radiol 37 (1996) 943-949
50. Duerk J.L., Lewin J.S., Wendt M., and Petersilge C. Remember true FISP? A high SNR, near 1-second imaging method for T2-like contrast in interventional MRI at .2 T. J Magn Reson Imaging 8 (1998) 203-208
51. Kiefer B., Grassner J., and Hausmann R. Image acquisition in a second with Half-Fourier single shot turbo spin-echo. J Magn Reson Imagin 4P (1994) 486-489
52. Nelson K.L., Gifford L.M., Lauber-Huber C., Gross C.A., and Lasser T.A. Clinical safety of gadopentetate dimeglumine. Radiology 196 (1996) 439-443
53. Low R.N., Sigeti J.S., Francis I.R., Weinman D., Bower B., Shimakawa A., et al. Evaluation of malignant biliary obstruction: efficacy of fast multiplanar spoiled gradient-recalled MR imaging vs spin-echo MR, CT and cholangiography. AJR 162 (1994) 315-323
54. Low R.N., Barone R.M., Lacey C., Sigeti J.S., Alzate G.D., and Sebrechts C.P. Peritoneal tumor: MR imaging with dilute oral barium and intravenous gadolinium-containing contrast agents compared with unenhanced MR imaging and CT. Radiology 204 (1997) 513-520
55. Low R.N., Francis I.R., Politoske D., and Bennett M. Crohn's disease evaluation: comparison of contrast-enhanced MR imaging and single phase helical CT scanning. J Magn Reson Imaging 11 (2000) 127-135
56. Rofsky N.M., Lee V.S., Laub G., Pollack M.A., Krinsky G.A., Thomasson D., et al. Abdominal MR imaging with a volumetric interpolated breath-hold examination. Radiology 212 (1999) 876-884
57. Earls J.P., Rofsky N.M., DeCorato D.R., Krinsky G.A., and Weinreb J.C. Hepatic arterial-phase dynamic gadolinium-enhanced MR imaging: optimization with a test examination and a power injector. Radiology 202 (1997) 268-273
58. Rummeny E.J., Torres C.G., Kurdziel J.C., Nilsen G., Op de Beeck B., and Lundby B. MnDPDP for MR imaging of the liver. Results of an independent image evaluation of the European phase III studies. Acta Radiol 38 4 pt 2 (1997) 638-642
59. Rofsky N.M., Weinreb J.C., Bernardino M.E., Young S.W., Lee J.K., and Noz M.E. Hepatocellular tumors: characterization with Mn-DPDP-enhanced MR imaging. Radiology 188 1 (1993) 53-59
60. Ward J., Guthrie J.A., Scott D.J., Atchley J., Wilson D., Davies M.H., et al. Hepatocellular carcinoma in the cirrhotic liver: double-contrast MR imaging for diagnosis. Radiology 216 1 (2000) 154-162
61. Schima W., Petersein J., Hahn P.F., Harisinghani M., Halpern E., and Saini S. Contrast-enhanced MR imaging of the liver: comparison between Gd-BOPTA and Mangafodipir. J Magn Reson Imaging 7 (1997) 130-135
62. Aicher K.P., Laniado M., Kopp A.F., Gronewaller E., Duda S.H., and Claussen C.D. Mn-DPDP-enhanced MR imaging of malignant liver lesions: efficacy and safety in 20 patients. J Magn Reson Imaging 3 (1993) 731-737
63. Gallez B., Baudelet C., Adline J., Charbon V., and Lambert D.M. The uptake of Mn-DPDP by hepatocytes is not medicated by the facilitated transport of pyridoxine. Magn Reson Imaging 14 (1996) 1191-1195
64. Lee V.S., Rofsky N.M., Morgan G.R., Teperman L.W., Krinsky G.A., Berman P., et al. Volumetric mangafodipir-trisodium-enhanced cholangiography to define intrahepatic biliary anatomy. AJR 176 4 (2001) 906-908
65. Mitchell D.G., and Alam F. Mangafodipir trisodium: effects on T2- and T1-weighted MR cholangiography. J Magn Reson Imaging 9 (1999) 366-368
66. Spinazzi A., Lorusso V., Pirovano G., and Kirchin A. Safety, tolerance, biodistribution, and MR imaging enhancement of the liver with gadobenate dimeglumine: results of clinical, pharmacologic and pilot imaging studies in non-patient and patient volunteers. Acad Radiol 6 5 (1999) 282-291
67. Hamm B., Staks T., Muhler A., Bollow M., Taupitz M., Frenzel T., et al. Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging. Radiology 195 3 (1995) 785-792
68. Scott J., Ward J., Guthrie J.A., Wilson D., and Robinson P.J. MRI of the liver: a comparison of CNR enhancement using high dose and low dose ferumoxide infusion in patients with colorectal liver metastases. Magn Reson Imaging 18 (2000) 297-303
69. Arnold P., Ward J., Wilson D., Guthrie J.A., and Robinson P.J. Superparamagnetic iron oxide (SPIO) enhancement in the cirrhotic liver: a comparison of two doses of ferumoxides in patients with advanced disease. Magn Reson Imaging 21 (2003) 695-700
70. Bluemke D.A., Weber T.M., Rubin D., de Lange E.E., Semelka R., Redvanly R.D., et al. Hepatic MR imaging with ferumoxides: multicenter study of safety and effectiveness of direct injection protocol. Radiology 228 2 (2003) 457-464
71. Reimer P., and Balzer T. Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications. Eur Radiol 13 (2003) 1266-1276
72. Murakami T., Baron R.L., Peterson M.S., Oliver III J.H., Davis P.L., Confer S.R., et al. Hepatocellular carcinoma: MR imaging with mangafodipir trisodium (Mn-DPDP). Radiology 200 (1996) 69-77
73. Seneterre E., Taourel P., Bouvier Y., Pradel J., Van Beers B., Daures J.P., et al. Detection of hepatic metastases: ferumoxides-enhanced MR imaging versus unenhanced MR imaging and CT during arterial portography. Radiology 200 (1996) 785-792
74. Helmberger T.K., Holzknecht N.G., and Gregor M.M. Unenhanced, Gd-DTPA- and ferumoxides-enhanced MRI in focal hepatic disease: a comparison in over 900 patients. Radiology 217 p (2000) 280
75. Coffin C.M., Diche T., Mahfouz A., Alexandre M., Caseiro-Alves F., Rahmouni A., et al. Benign and malignant hepatocellular tumors: evaluation of tumoral enhancement after mangafodipir trisodium injection on MR imaging. Eur Radiol 9 (1999) 444-449
76. Mathieu D., Coffin C., Kobeiter H., Caseiro-Alves F., and Mahfouz A. Rahmouni A et al. Unexpected MR-T1 enhancement of endocrine liver metastases with mangafodipir. J Magn Reson Imaging 10 (1999) 193-195
77. Hahn P.F., Stark D.D., Weissleder R., Elizondo G., Saini S., and Ferrucci J.T. Clinical application of superparamagnetic iron oxide to MR imaging of tissue perfusion in vascular liver tumors. Radiology 174 (1990) 361-366
78. Ward J., and Robinson P.J. Combined use of MR contrast agents for evaluating liver disease. MRI Clinics N Am 9 4 (2001) 767-783
79. Bhartia B., Ward J., Guthrie J.A., and Robinson P.J. Hepatocellular carcinoma in cirrhotic livers: double-contrast thin-section MR imaging with pathologic correlation of explanted tissue. Am J Roentgenol 180 3 (2003) 577-584